Sign In
Buy DGX
$193.67
+0.510 (+0.264%)
At Close: Jun 03, 2026
Quest Diagnostics to Speak at the 2024 Leerink Partners Healthcare Crossroads Conference
04:50pm, Tuesday, 07'th May 2024
SECAUCUS, N.J. , May 7, 2024 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will speak
Quest Diagnostics (DGX) Grows in Digital Pathology With New Deal
12:26pm, Tuesday, 07'th May 2024
Quest Diagnostics' (DGX) pathology laboratories nationwide are set to get a boost with PathAI's AISight digital pathology image management system.
Quest Diagnostics Names Murali Balakumar Senior Vice President and Chief Information and Digital Officer
09:40am, Monday, 06'th May 2024
SECAUCUS, N.J. , May 6, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, announced today that Murali Balakumar, a veteran information technol
Reasons to Retain Quest Diagnostics (DGX) Stock for Now
11:46am, Thursday, 02'nd May 2024
Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.
Quest Diagnostics (DGX) Inks Deal to Acquire PathAI Diagnostics
10:05am, Thursday, 02'nd May 2024
Quest Diagnostics' (DGX) latest transaction combines its oncology expertise and scale with PathAI's AI and digital pathology innovations.
Transaction is part of wide-ranging collaboration to combine Quest's oncology expertise and scale with PathAI's AI and digital pathology innovations to speed diagnosis, improve quality and reduce cost
FDA brings lab tests under federal oversight in bid to improve accuracy and safety
07:21pm, Monday, 29'th Apr 2024
WASHINGTON — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorou
Quest Diagnostics (DGX) Q1 Earnings Top Estimates, Margins Down
10:56am, Tuesday, 23'rd Apr 2024
Quest Diagnostics (DGX) continues its strong momentum of base business revenue growth in the first quarter of 2024.
Quest Diagnostics (DGX) Beats Q1 Earnings and Revenue Estimates
08:56am, Tuesday, 23'rd Apr 2024
Quest Diagnostics (DGX) came out with quarterly earnings of $2.04 per share, beating the Zacks Consensus Estimate of $1.86 per share. This compares to earnings of $2.04 per share a year ago.
Quest Diagnostics raises 2024 profit and revenue forecast on strong demand
08:02am, Tuesday, 23'rd Apr 2024
Laboratory operator Quest Diagnostic raised its 2024 profit and revenue forecast on Tuesday after beating first-quarter estimates on robust demand for its diagnostic tests.
Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024
06:45am, Tuesday, 23'rd Apr 2024
First quarter revenues of $2.37 billion, up 1.5% from 2023 First quarter reported diluted earnings per share ("EPS") of $1.72, down 3.4% from 2023; and adjusted diluted EPS of $2.04, flat with 2023 Fu
Unlocking Q1 Potential of Quest Diagnostics (DGX): Exploring Wall Street Estimates for Key Metrics
10:21am, Monday, 22'nd Apr 2024
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Quest Diagnostics (DGX), delve into some of its key metrics to gain a deeper insight into the company's potential performance f
Company's AD-Detect™ Portfolio Offers AB 42/40 and Other Plasma Biomarker Testing, Alongside Traditional Cerebrospinal Fluid and Genetic Tests, to Provide Robust Offering in Brain Health SECAUCUS, N
Earnings Preview: Quest Diagnostics (DGX) Q1 Earnings Expected to Decline
11:06am, Tuesday, 16'th Apr 2024
Quest Diagnostics (DGX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Quest Diagnostics (DGX) to Post Q1 Earnings: What's in Store?
10:51am, Monday, 15'th Apr 2024
Acquisitions and partnerships with health plans are expected to drive Quest Diagnostics' (DGX) base business performance in the first quarter of 2024.
